We are not supporting this browser

Importance of sensory alterations for cancer patients with taste alteration

The Journal of Supportive Care in Cancer published a new study, showing that taste and smell alterations are common in patients receiving systemic antitumor therapy and that nutritional support specifically designed to better address sensory alterations, is appreciated in these patients.

Common in patients with cancer undergoing systemic anti-cancer, taste and smell alterations may develop throughout the course of cancer (before and during) and last up to one year after treatment1, with up to 70% of cancer patients experiencing taste changes during chemotherapy and radiotherapy2.

Sensory alterations in advanced cancer are associated with a substantial decrease in caloric intake, increase risk of malnutrition, poorer social-emotional function and overall quality of life. Nutritional interventions in cancer patients such as Oral Nutritional Supplements (ONS) can improve overall energy and protein intake, overall body weight, muscle mass and quality of life.

In line with previous findings, this new study called “Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory adapted flavours in cancer patients receiving systemic antitumor treatment” shows that:

  • Overall, 60% of patients who participated in this study reported taste alterations, and taste alterations were reported to adversely impact on patients daily life.
  • Patients with taste alterations demonstrated a large variation in overall liking score per ONS flavour compared to patients without taste alterations.
  • Sensory adapted flavours appear to be appreciated in patients with taste alterations and appreciation of taste can impact product adherence and ultimately patients’ recovery.

It is important healthcare professionals consider above findings when selecting or prescribing Oral Nutritional Supplements for cancer patients and take into consideration ONS flavors preferences for better product adherence.

Read more
  1. Spotten, 2017
  2. Spotten, 2017, (Bernhardson et al, 2008; Wickham et al, 1999

Nutricia uses cookies on this website. With your consent we will use them to measure and analyze usage of the website (analytical cookies), to tailor it to your interests (personalisational cookies), and to present you relevant advertising and information (targeting cookies). For more information please read the cookie policy.

Privacy Settings

You can choose your preferences anytime for cookies and tracking. For more information please read our cookie policy.

  • Strictly necessary

    They are necessary for the website to function and cannot be switched off. They are usually only set in response to actions made by you which amount to a request for services (setting your privacy preferences, logging in, filling in forms, etc.). You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.

  • Analytical cookies

    They allow us to count visits and traffic sources, to measure and improve the performance of our site. They show us which pages are the most and least popular and how visitors move around the site. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

  • Personalisation cookies

    They enable website’s enhanced functionality and personalisation. They may be set by us or by third parties whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

  • Targeting cookies

    They may be set through our site by our advertising partners, to build a profile of your interests and to show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.